Everett Harris & Co. CA decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,133 shares of the medical equipment provider’s stock after selling 145 shares during the quarter. Everett Harris & Co. CA’s holdings in Intuitive Surgical were worth $2,679,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the company. Bennett Selby Investments LP boosted its position in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares in the last quarter. LVW Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. grew its position in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after acquiring an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on ISRG. BTIG Research raised their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.
Insider Buying and Selling at Intuitive Surgical
In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is currently owned by company insiders.
Intuitive Surgical Trading Down 1.4 %
NASDAQ:ISRG opened at $571.88 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a 50-day moving average price of $549.92 and a 200-day moving average price of $508.00. The stock has a market cap of $203.69 billion, a price-to-earnings ratio of 89.22, a P/E/G ratio of 5.52 and a beta of 1.39.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- How to Profit From Value Investing
- MarketBeat Week in Review – 01/27 – 01/31
- What to Know About Investing in Penny Stocks
- Trump 2.0: This Sector May See A Big Performance Boost
- How to Invest in Small Cap Stocks
- Nebius Group: Market Overreaction or Real AI Disruption?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.